These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23981530)

  • 41. Activation and desensitization of TRPV1 channels in sensory neurons by the PPARα agonist palmitoylethanolamide.
    Ambrosino P; Soldovieri MV; Russo C; Taglialatela M
    Br J Pharmacol; 2013 Mar; 168(6):1430-44. PubMed ID: 23083124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The glutamatergic nature of TRPV1-expressing neurons in the spinal dorsal horn.
    Zhou HY; Chen SR; Chen H; Pan HL
    J Neurochem; 2009 Jan; 108(1):305-18. PubMed ID: 19012737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transient receptor potential vanilloid subtype 1 mediates microglial cell death in vivo and in vitro via Ca2+-mediated mitochondrial damage and cytochrome c release.
    Kim SR; Kim SU; Oh U; Jin BK
    J Immunol; 2006 Oct; 177(7):4322-9. PubMed ID: 16982866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. α-Substituted 2-(3-fluoro-4-methylsulfonamidophenyl)acetamides as potent TRPV1 antagonists.
    Tran PT; Kim HS; Ann J; Kim SE; Kim C; Hong M; Hoang VH; Ngo VT; Hong S; Cui M; Choi S; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2326-30. PubMed ID: 25937016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stereospecific high-affinity TRPV1 antagonists: chiral N-(2-benzyl-3-pivaloyloxypropyl) 2-[4-(methylsulfonylamino)phenyl]propionamide analogues.
    Ryu H; Jin MK; Kim SY; Choi HK; Kang SU; Kang DW; Lee J; Pearce LV; Pavlyukovets VA; Morgan MA; Tran R; Toth A; Lundberg DJ; Blumberg PM
    J Med Chem; 2008 Jan; 51(1):57-67. PubMed ID: 18072720
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Miogadial and miogatrial with alpha,beta-unsaturated 1,4-dialdehyde moieties--novel and potent TRPA1 agonists.
    Iwasaki Y; Tanabe M; Kayama Y; Abe M; Kashio M; Koizumi K; Okumura Y; Morimitsu Y; Tominaga M; Ozawa Y; Watanabe T
    Life Sci; 2009 Jul; 85(1-2):60-9. PubMed ID: 19409911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure-activity relationships of vanilloid receptor agonists for arteriolar TRPV1.
    Czikora Á; Lizanecz E; Bakó P; Rutkai I; Ruzsnavszky F; Magyar J; Pórszász R; Kark T; Facskó A; Papp Z; Édes I; Tóth A
    Br J Pharmacol; 2012 Mar; 165(6):1801-1812. PubMed ID: 21883148
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Participation of the spinal TRPV1 receptors in formalin-evoked pain transduction: a study using a selective TRPV1 antagonist, iodo-resiniferatoxin.
    Kanai Y; Hara T; Imai A
    J Pharm Pharmacol; 2006 Apr; 58(4):489-93. PubMed ID: 16597366
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kinetics of penetration influence the apparent potency of vanilloids on TRPV1.
    Lazar J; Braun DC; Tóth A; Wang Y; Pearce LV; Pavlyukovets VA; Blumberg PM; Garfield SH; Wincovitch S; Choi HK; Lee J
    Mol Pharmacol; 2006 Apr; 69(4):1166-73. PubMed ID: 16418338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detailed Analysis of the Binding Mode of Vanilloids to Transient Receptor Potential Vanilloid Type I (TRPV1) by a Mutational and Computational Study.
    Ohbuchi K; Mori Y; Ogawa K; Warabi E; Yamamoto M; Hirokawa T
    PLoS One; 2016; 11(9):e0162543. PubMed ID: 27606946
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Similar and different effects of capsaicin and resiniferatoxin on substance P release and transient receptor potential vanilloid type 1 expression of cultured rat dorsal root ganglion neurons.
    Yang X; Gong H; Liu Z; Liu H; Wang H; Li Z
    Methods Find Exp Clin Pharmacol; 2010; 32(1):3-11. PubMed ID: 20383340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TRPV1 activation is not an all-or-none event: TRPV1 partial agonism/antagonism and its regulatory modulation.
    Blumberg PM; Pearce LV; Lee J
    Curr Top Med Chem; 2011; 11(17):2151-8. PubMed ID: 21671879
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pungency of TRPV1 agonists is directly correlated with kinetics of receptor activation and lipophilicity.
    Ursu D; Knopp K; Beattie RE; Liu B; Sher E
    Eur J Pharmacol; 2010 Sep; 641(2-3):114-22. PubMed ID: 20576527
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pain control through selective chemo-axotomy of centrally projecting TRPV1+ sensory neurons.
    Sapio MR; Neubert JK; LaPaglia DM; Maric D; Keller JM; Raithel SJ; Rohrs EL; Anderson EM; Butman JA; Caudle RM; Brown DC; Heiss JD; Mannes AJ; Iadarola MJ
    J Clin Invest; 2018 Apr; 128(4):1657-1670. PubMed ID: 29408808
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Opening of capsaicin receptor TRPV1 is stabilized equally by its four subunits.
    Li S; Nguyen PT; Vu S; Yarov-Yarovoy V; Zheng J
    J Biol Chem; 2023 Jun; 299(6):104828. PubMed ID: 37196769
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation of vanilloid receptor type I in the endoplasmic reticulum fails to activate store-operated Ca2+ entry.
    Wisnoskey BJ; Sinkins WG; Schilling WP
    Biochem J; 2003 Jun; 372(Pt 2):517-28. PubMed ID: 12608892
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The vanilloid agonist resiniferatoxin for interventional-based pain control.
    Iadarola MJ; Mannes AJ
    Curr Top Med Chem; 2011; 11(17):2171-9. PubMed ID: 21671877
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selective ablation of TRPV1 by intrathecal injection of resiniferatoxin in rats increases renal sympathoexcitatory responses and salt sensitivity.
    Yu SQ; Ma S; Wang DH
    Hypertens Res; 2018 Sep; 41(9):679-690. PubMed ID: 30006640
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Depressive behavior in the forced swim test can be induced by TRPV1 receptor activity and is dependent on NMDA receptors.
    Abdelhamid RE; Kovács KJ; Nunez MG; Larson AA
    Pharmacol Res; 2014 Jan; 79():21-7. PubMed ID: 24200896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of the vanilloid receptor 1 antagonist iodo-resiniferatoxin on the afferent and efferent function of vagal sensory C-fibers.
    Undem BJ; Kollarik M
    J Pharmacol Exp Ther; 2002 Nov; 303(2):716-22. PubMed ID: 12388656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.